Prevalence of vascular risk factors among Spanish populations aged 70 years and over, as reported in door-to-door studies on neurological diseases;Prevalencia de faetores de riesgo vascular en poblaeiones Españolas de 70 años y más en estudios puerta a puerta de enfermedades neurológicas

Neurologia

Volumn 22, Issue 3, 2007, Pages 138-146

  Del Barrio, José Luis ^a   Medrano, M J ^a   Arce, A ^b   Bergareche, A ^c   Bermejo, F ^d   Diaz J ^d   Gascon J ^e   Garcia F J ^f   Garre J ^g   Gomez C ^h   Lobo, A ⁱ   Martinez A ^d   Otero, A ^j   Rene R ^e   Sanchez M I ^f   Saz, P ⁱ   Vega, S ^h   Vilalta Franch, J ^g   Zunzunegui, M V ^k   De Pedro, J ^a  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c Hospital Bidasoa   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f HOSPITAL VIRGEN DE LA SALUD   (Spain)

^g Parque Hospitalario Marti i Julia   (Spain)

^h Health Center of Arévalo   (Spain)

ⁱ UNIVERSITY OF ZARAGOZA   (Spain)

^j UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^k UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

Door to door; Neurological studies; Vascular risk factors

Indexed keywords

AGED; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR RISK; DEMENTIA; DIABETES MELLITUS; FEMALE; GEOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PARKINSONISM; PREVALENCE; RISK FACTOR; SELF REPORT; SMOKING; STROKE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; HEALTH SURVEY; META ANALYSIS; METHODOLOGY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SPAIN; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS; FEMALE; HEALTH SURVEYS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; PREVALENCE; QUESTIONNAIRES; RESEARCH DESIGN; RISK FACTORS; SMOKING; SPAIN; VASCULAR DISEASES;

EID: 34247490100     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Plan Integral de Cardiopatía Isquémica 2004-2007. Madrid: Ministerio de Sanidad y Consumo, 2003.
2. Instituto Nacional de Estadística. INEbase. Estadísticas Demográficas. Disponible en: http://www.ine.es/inebase. Consultado el 18 de oetubre de 2005.
3. a Monografía de la Sociedad Española de Epidemiología. Madrid, 2005.
4. World Health Organization. The World Health Report 2002: reducing risk, promoting healthy life. Geneve: WHO, 2002.
5. Medrano MJ, Cerrato E, Boix R, Delgado-Rodríguez M. Factores de riesgo cardiovascular en la población española: metaanálisis de estudios transversales. Med Clin (Barc) 2005;124:606-12.
6. Gabriel Sánchez R, Alonso Arroyo M, Bermejo Pareja F, Muñiz García J, López Rodríguez I, Suárez Fernández C, et al. Proyecto EPICARDIAN: estudio epidemiológico sobre enfermedades y factores de riesgo cardiovasculares en ancianos españoles. Diseño, métodos y resultados preliminares. Rev Esp Geriatr Gerontol 1996;31:327-34.
7. Belza MJ, Quiroga J, Beland F, Zunzunegui MV. La hipertensión en las personas ancianas: prevalencia, conocimiento, tratamiento y control. Aten Primaria 1997;19:367-71.
8. Suárez C, del Arco C, Sáez T, Blanco F, Ruiz JM, Alonso M, et al. Monitorización ambulatoria de la presión arterial en ancianos. Estudio EPICARDIAN. Rev Esp Cardiol 1998;51:965-71.
9. Banegas JR, Rodríguez Artalejo F, Ruilope LM, Graeiani A, Luque M, de la Cruz Troca JJ, et al. Hypertension magnitude and management in the elderly population of Spain. J Hypert 2002;20:2157-64.
10. Del Barrio JL, de Pedro-Cuesta J, Boix R, Acosta J, Bergareche A, Bermejo-Pareja F, et al. Dementia, stroke and Parkinson's disease in Spanish populations: a review of door-to-door prevalence surveys. Neuroepidemiology 2005;24:179-88.
11. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhäger WH, Babarskiene MR, et al, on behalf of the Syst-Eur Investigators. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-51.
12. Morales JM, Bermejo FP, Benito-León J, Rivera-Navarro J, Trincado R, Gabriel SR, et al.; NEDICES Study Group. Methods and demographic findings of the baseline survey of the NEDICES cohort: a door-to-door survey of neurological disorders in three communities from Central Spain. Public Health 2004;118:426-33.
13. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MMB, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54(Suppl. 5):S4-S9.
14. Rijk MC, Launer LJ, Berger K, Breteler MMB, Dartigues JF, Baldereschi M, et al for the Neurologic Diseases in the Elderly Research Group. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurology 2000; 54(Suppl. 5):S21-S23.
15. Di Carlo A, Launer LJ, Breteler MM, Fratiglioni MD, Lobo A, Martínez-Lage J, et al. Frequency of stroke in Europe: a collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group. Neurology 2000;54(Suppl. 5):S28-33.
16. Bergareche A, de la Puente E, López de Munain A, Sarasqueta C, de Arce A, Poza JJ, et al. Prevalence of Parkinson's disease and other types of Parkinsonism. A door-to-door survey in Bidasoa, Spain. J Neurol 2004;251:340-5.
17. Bergareche A, de la Puente E, López de Munain A, Sarasqueta C, de Arce A, Poza JJ, et al. Prevalence of essential tremor: a door-to-door survey in Bidasoa, Spain. Neuroepidemiology 2001;20:125-8
18. García FJ, Sánchez MA, Pérez A, Martín E, Marsal C, Rodríguez G, et al. Prevalencia de demencia y de sus subtipos principals en sujetos mayores de 65 años: efecto de la educación y ocupación. Estudio Toledo. Med Clin (Barc) 2001;116:401-7.
19. Zunzunegui MV, del Ser T, Rodríguez A, García MJ, Domingo J, Otero A. Demencia no detectada y utilización de los servicios sanitarios: implicaciones para la atención primaria. Aten Primaria 2003;31:581-6.
20. Vilalta-Franch J, López-Pousa S, Llinás-Reglá. Prevalencia de demencias en una zona rural. Estudio de Girona. Rev Neurol 2000;30:1026-32.
21. Ministerio de Sanidad y Consumo. Encuesta Nacional de Salud de España 2003. Disponible en: http: //www.msc.es/Diseno//sns/ sns_sistemas_informacion.htm. Consultado el 18 de octubre de 2005.
22. Casserly I, Topol E. Convergence of atherosclerotis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 2004;363:1139-46.
23. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 1997;42:776-82.
24. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, et al. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 1998;17:14-20.
25. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikaien M, Alhainen K, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001;322:1447-51.
26. Dufouil C, Richard F, Fievet N, Dartigues JF, Ritchie K, Tzourio C, et al. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology 2005;64:1531-8,
27. Peila R, Rodríguez BL, Launer LJ. Honolulu-Asia Aging Study. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 2002;51: 1256-62.
28. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999;53:1937-42.
29. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-5.
30. Launer LJ, Ross GW, Petrovich H, Masaki K, Foley D, White LR, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 2000;21:49-55.
31. Wolf-Maier K, Cooper R, Banegas JR, Giampaoli S, Hans-Werner H, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:2363-9.
32. Ford E, Mokdad A, Giles W, Mensah G. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003;107:2185-9.